Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model

Anttila, V.; Bulik-Sullivan, B.; Finucane, H.K.; Walters, R.K.; Bras, J.; Duncan, L.; Escott-Price, V.; Falcone, G.J.; Gormley, P.; Malik, R.; Patsopoulos, N.A.; Ripke, S.; Wei, Z.; Yu, D.; Lee, P.H.; Turley, P.; Grenier-Boley, B.; Chouraki, V.; Kamatani, Y.; Berr, C.; Letenneur, L.; Hannequin, D.; Amouyel, P.; Boland, A.; Deleuze, J.F.; Duron, E.; Vardarajan, B.N.; Reitz, C.; Goate, A.M.; Huentelman, M.J.; Kamboh, M.I.; Larson, E.B.; Rogaeva, E.; St George-Hyslop, P.; Hakonarson, H.; Kukull, W.A.; Farrer, L.A.; Barnes, L.L.; Beach, T.G.; Demirci, F.Y.; Head, E.; Hulette, C.M.; Jicha, G.A.; Kauwe, J.S.K.; Kaye, J.A.; Leverenz, J.B.; Levey, A.I.; Lieberman, A.P.; Pankratz, V.S.; Poon, W.W.; Quinn, J.F.; Saykin, A.J.; Schneider, L.S.; Smith, A.G.; Sonnen, J.A.; Stern, R.A.; Van Deerlin, V.M.; Van Eldik, L.J.; Harold, D.; Russo, G.; Rubinsztein, D.C.; Bayer, A.; Tsolaki, M.; Proitsi, P.; Fox, N.C.; Hampel, H.; Owen, M.J.; Mead, S.; Passmore, P.; Morgan, K.; Nöthen, M.M.; Rossor, M.; Lupton, M.K.; Hoffmann, P.; Kornhuber, J.; Lawlor, B.; McQuillin, A.; Al-Chalabi, A.; Bis, J.C.; Ruiz, A.; Boada, M.; Seshadri, S.; Beiser, A.; Rice, K.; van der Lee, S.J.; De Jager, P.L.; Geschwind, D.H.; Riemenschneider, M.; Riedel-Heller, S.; Rotter, J.I.; Ransmayr, G.; Hyman, B.T.; Cruchaga, C.; Alegret, M.; Winsvold, B.; Palta, P.; Farh, K.H.; Cuenca-Leon, E.; Furlotte, N.; Kurth, T.; Ligthart, L.; Terwindt, G.M.; Freilinger, T.; Ran, C.; Gordon, S.D.; Borck, G.; Adams, H.H.H.; Lehtimäki, T.; Wedenoja, J.; Buring, J.E.; Schürks, M.; Hrafnsdottir, M.; Hottenga, J.J.; Penninx, B.; Artto, V.; Kaunisto, M.; Vepsäläinen, S.; Martin, N.G.; Montgomery, G.W.; Kurki, M.I.; Hämäläinen, E.; Huang, H.; Huang, J.; Sandor, C.; Webber, C.; Muller-Myhsok, B.; Schreiber, S.; Salomaa, V.; Loehrer, E.; Göbel, H.; Macaya, A.; Pozo-Rosich, P.; Hansen, T.; Werge, T.; Kaprio, J.; Metspalu, A.; Kubisch, C.; Ferrari, M.D.; Belin, A.C.; van den Maagdenberg, A.M.J.M.; Zwart, J.A.; Boomsma, D.; Eriksson, N.; Olesen, J.; Chasman, D.I.; Nyholt, D.R.; Avbersek, A.; Baum, L.; Berkovic, S.; Bradfield, J.; Buono, R.J.; Catarino, C.B.; Cossette, P.; De Jonghe, P.; Depondt, C.; Dlugos, D.; Ferraro, T.N.; French, J.; Hjalgrim, H.; Jamnadas-Khoda, J.; Kälviäinen, R.; Kunz, W.S.; Lerche, H.; Leu, C.; Lindhout, D.; Lo, W.; Lowenstein, D.; McCormack, M.; Møller, R.S.; Molloy, A.; Ng, P.W.; Oliver, K.; Privitera, M.; Radtke, R.; Ruppert, A.K.; Sander, T.; Schachter, S.; Schankin, C.; Scheffer, I.; Schoch, S.; Sisodiya, S.M.; Smith, P.; Sperling, M.; Striano, P.; Surges, R.; Thomas, G.N.; Visscher, F.; Whelan, C.D.; Zara, F.; Heinzen, E.L.; Marson, A.; Becker, F.; Stroink, H.; Zimprich, F.; Gasser, T.; Gibbs, R.; Heutink, P.; Martinez, M.; Morris, H.R.; Sharma, M.; Ryten, M.; Mok, K.Y.; Pulit, S.; Bevan, S.; Holliday, E.; Attia, J.; Battey, T.; Boncoraglio, G.; Thijs, V.; Chen, W.M.; Mitchell, B.; Rothwell, P.; Sharma, P.; Sudlow, C.; Vicente, A.; Markus, H.; Kourkoulis, C.; Pera, J.; Raffeld, M.; Silliman, S.; Boraska Perica, V.; Thornton, L.M.; Huckins, L.M.; William Rayner, N.; Lewis, C.M.; Gratacos, M.; Rybakowski, F.; Keski-Rahkonen, A.; Raevuori, A.; Hudson, J.I.; Reichborn-Kjennerud, T.; Monteleone, P.; Karwautz, A.; Mannik, K.; Baker, J.H.; O’Toole, J.K.; Trace, S.E.; Davis, O.S.P.; Helder, S.G.; Ehrlich, S.; Herpertz-Dahlmann, B.; Danner, U.N.; van Elburg, A.A.; Clementi, M.; Forzan, M.; Docampo, E.; Lissowska, J.; Hauser, J.; Tortorella, A.; Maj, M.; Gonidakis, F.; Tziouvas, K.; Papezova, H.; Yilmaz, Z.; Wagner, G.; Cohen-Woods, S.; Herms, S.; Julià, A.; Rabionet, R.; Dick, D.M.; Ripatti, S.; Andreassen, O.A.; Espeseth, T.; Lundervold, A.J.; Steen, V.M.; Pinto, D.; Scherer, S.W.; Aschauer, H.; Schosser, A.; Alfredsson, L.; Padyukov, L.; Halmi, K.A.; Mitchell, J.; Strober, M.; Bergen, A.W.; Kaye, W.; Szatkiewicz, J.P.; Cormand, B.; Ramos-Quiroga, J.A.; Sánchez-Mora, C.; Ribasés, M.; Casas, M.; Hervas, A.; Arranz, M.J.; Haavik, J.; Zayats, T.; Johansson, S.; Williams, N.; Dempfle, A.; Rothenberger, A.; Kuntsi, J.; Oades, R.D.; Banaschewski, T.; Franke, B.; Buitelaar, J.K.; Arias Vasquez, A.; Doyle, A.E.; Reif, A.; Lesch, K.P.; Freitag, C.; Rivero, O.; Palmason, H.; Romanos, M.; Langley, K.; Rietschel, M.; Witt, S.H.; Dalsgaard, S.; Børglum, A.D.; Waldman, I.; Wilmot, B.; Molly, N.; Bau, C.H.D.; Crosbie, J.; Schachar, R.; Loo, S.K.; McGough, J.J.; Grevet, E.H.; Medland, S.E.; Robinson, E.; Weiss, L.A.; Bacchelli, E.; Bailey, A.; Bal, V.; Battaglia, A.; Betancur, C.; Bolton, P.; Cantor, R.; Celestino-Soper, P.; Dawson, G.; De Rubeis, S.; Duque, F.; Green, A.; Klauck, S.M.; Leboyer, M.; Levitt, P.; Maestrini, E.; Mane, S.; De-Luca, D.M.; Parr, J.; Regan, R.; Reichenberg, A.; Sandin, S.; Vorstman, J.; Wassink, T.; Wijsman, E.; Cook, E.; Santangelo, S.; Delorme, R.; Rogé, B.; Magalhaes, T.; Arking, D.; Schulze, T.G.; Thompson, R.C.; Strohmaier, J.; Matthews, K.; Melle, I.; Morris, D.; Blackwood, D.; McIntosh, A.; Bergen, S.E.; Schalling, M.; Jamain, S.; Maaser, A.; Fischer, S.B.; Reinbold, C.S.; Fullerton, J.M.; Guzman-Parra, J.; Mayoral, F.; Schofield, P.R.; Cichon, S.; Mühleisen, T.W.; Degenhardt, F.; Schumacher, J.; Bauer, M.; Mitchell, P.B.; Gershon, E.S.; Rice, J.; Potash, J.B.; Zandi, P.P.; Craddock, N.; Ferrier, I.N.; Alda, M.; Rouleau, G.A.; Turecki, G.; Ophoff, R.; Pato, C.; Anjorin, A.; Stahl, E.; Leber, M.; Czerski, P.M.; Cruceanu, C.; Jones, I.R.; Posthuma, D.; Andlauer, T.F.M.; Forstner, A.J.; Streit, F.; Baune, B.T.; Air, T.; Sinnamon, G.; Wray, N.R.; MacIntyre, D.J.; Porteous, D.; Homuth, G.; Rivera, M.; Grove, J.; Middeldorp, C.M.; Hickie, I.; Pergadia, M.; Mehta, D.; Smit, J.H.; Jansen, R.; de Geus, E.; Dunn, E.; Li, Q.S.; Nauck, M.; Schoevers, R.A.; Beekman, A.T.; Knowles, J.A.; Viktorin, A.; Arnold, P.; Barr, C.L.; Bedoya-Berrio, G.; Bienvenu, O.J.; Brentani, H.; Burton, C.; Camarena, B.; Cappi, C.; Cath, D.; Cavallini, M.; Cusi, D.; Darrow, S.; Denys, D.; Derks, E.M.; Dietrich, A.; Fernandez, T.; Figee, M.; Freimer, N.; Gerber, G.; Grados, M.; Greenberg, E.; Hanna, G.L.; Hartmann, A.; Hirschtritt, M.E.; Hoekstra, P.J.; Huang, A.; Huyser, C.; Illmann, C.; Jenike, M.; Kuperman, S.; Leventhal, B.; Lochner, C.; Lyon, G.J.; Macciardi, F.; Madruga-Garrido, M.; Malaty, I.A.; Maras, A.; McGrath, L.; Miguel, E.C.; Mir, P.; Nestadt, G.; Nicolini, H.; Okun, M.S.; Pakstis, A.; Paschou, P.; Piacentini, J.; Pittenger, C.; Plessen, K.; Ramensky, V.; Ramos, E.M.; Reus, V.; Richter, M.A.; Riddle, M.A.; Robertson, M.M.; Roessner, V.; Rosário, M.; Samuels, J.F.; Sandor, P.; Stein, D.J.; Tsetsos, F.; Van Nieuwerburgh, F.; Weatherall, S.; Wendland, J.R.; Wolanczyk, T.; Worbe, Y.; Zai, G.; Goes, F.S.; McLaughlin, N.; Nestadt, P.S.; Grabe, H.J.; Depienne, C.; Konkashbaev, A.; Lanzagorta, N.; Valencia-Duarte, A.; Bramon, E.; Buccola, N.; Cahn, W.; Cairns, M.; Chong, S.A.; Cohen, D.; Crespo-Facorro, B.; Crowley, J.; Davidson, M.; DeLisi, L.; Dinan, T.; Donohoe, G.; Drapeau, E.; Duan, J.; Haan, L.; Hougaard, D.; Karachanak-Yankova, S.; Khrunin, A.; Klovins, J.; Kučinskas, V.; Lee Chee Keong, J.; Limborska, S.; Loughland, C.; Lönnqvist, J.; Maher, B.; Mattheisen, M.; McDonald, C.; Murphy, K.C.; Nenadic, I.; van Os, J.; Pantelis, C.; Pato, M.; Petryshen, T.; Quested, D.; Roussos, P.; Sanders, A.R.; Schall, U.; Schwab, S.G.; Sim, K.; So, H.C.; Stögmann, E.; Subramaniam, M.; Toncheva, D.; Waddington, J.; Walters, J.; Weiser, M.; Cheng, W.; Cloninger, R.; Curtis, D.; Gejman, P.V.; Henskens, F.; Mattingsdal, M.; Oh, S.Y.; Scott, R.; Webb, B.; Breen, G.; Churchhouse, C.; Bulik, C.M.; Daly, M.; Dichgans, M.; Faraone, S.V.; Guerreiro, R.; Holmans, P.; Kendler, K.S.; Koeleman, B.; Mathews, C.A.; Price, A.; Scharf, J.; Sklar, P.; Williams, J.; Wood, N.W.; Cotsapas, C.; Palotie, A.; Smoller, J.W.; Sullivan, P.; Rosand, J.; Corvin, A.; Neale, B.M.; Schott, J.M.; Anney, R.; Elia, J.; Grigoroiu-Serbanescu, M.; Edenberg, H.J.; Murray, R. Analysis of shared heritability in common disorders of the brain. Science, 2018, 360(6395), eaap8757.
[http://dx.doi.org/10.1126/science.aap8757] [PMID: 29930110]

Hernandez, L.M.; Kim, M.; Hoftman, G.D.; Haney, J.R.; de la Torre-Ubieta, L.; Pasaniuc, B.; Gandal, M.J. Transcriptomic insight into the polygenic mechanisms underlying psychiatric disorders. biol. Psychiatry, 2021, 89(1), 54-64.
[http://dx.doi.org/10.1016/j.biopsych.2020.06.005] [PMID: 32792264]

Yan, L.; Zhang, W. Precision medicine becomes reality-tumor type-agnostic therapy. Cancer Commun. (Lond.), 2018, 38(1), 6.
[http://dx.doi.org/10.1186/s40880-018-0274-3] [PMID: 29764494]

Goldberg, K.B.; Blumenthal, G.M.; McKee, A.E.; Pazdur, R. The FDA Oncology Center of Excellence and precision medicine. Exp. Biol. Med. (Maywood), 2018, 243(3), 308-312.
[http://dx.doi.org/10.1177/1535370217740861] [PMID: 29105511]

Blumenthal, G.M.; Goldberg, K.B.; Pazdur, R. Drug development, trial design, and endpoints in oncology: Adapting to rapidly changing science. Clin. Pharmacol. Ther., 2017, 101(5), 572-574.
[http://dx.doi.org/10.1002/cpt.623] [PMID: 28074476]

Arenaza-Urquijo, E.M.; Vemuri, P. Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies. Neurology, 2018, 90(15), 695-703.
[http://dx.doi.org/10.1212/WNL.0000000000005303] [PMID: 29592885]

Hampel, H.; Lista, S.; Neri, C.; Vergallo, A. Time for the systems-level integration of aging: Resilience enhancing strategies to prevent Alzheimer’s disease. Prog. Neurobiol., 2019, 181, 101662.
[http://dx.doi.org/10.1016/j.pneurobio.2019.101662] [PMID: 31351912]

Ressler, K.J.; Williams, L.M. Big data in psychiatry: multiomics, neuroimaging, computational modeling, and digital phenotyping. Neuropsychopharmacology, 2021, 46(1), 1-2.
[http://dx.doi.org/10.1038/s41386-020-00862-x] [PMID: 32919403]

Hampel, H.; Nisticò, R.; Seyfried, N.T.; Levey, A.I.; Modeste, E.; Lemercier, P.; Baldacci, F.; Toschi, N.; Garaci, F.; Perry, G.; Emanuele, E.; Valenzuela, P.L.; Lucia, A.; Urbani, A.; Sancesario, G.M.; Mapstone, M.; Corbo, M.; Vergallo, A.; Lista, S. Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence. Ageing Res. Rev., 2021, 69, 101346.
[http://dx.doi.org/10.1016/j.arr.2021.101346] [PMID: 33915266]

Yan, R.; Vassar, R. Targeting the β secretase BACE1 for Alzheimer’s disease therapy. Lancet Neurol., 2014, 13(3), 319-329.
[http://dx.doi.org/10.1016/S1474-4422(13)70276-X] [PMID: 24556009]

Vassar, R. BACE1: the beta-secretase enzyme in Alzheimer’s disease. J. Mol. Neurosci., 2004, 23(1-2), 105-114.
[http://dx.doi.org/10.1385/JMN:23:1-2:105] [PMID: 15126696]

Hampel, H.; Vassar, R.; De Strooper, B.; Hardy, J.; Willem, M.; Singh, N. The β-Secretase BACE1 in Alzheimer’s Disease. Biol. Psychiatry, 2021, 89(8), 745-756.
[http://dx.doi.org/10.1016/j.biopsych.2020.02.001] [PMID: 32223911]

Head, E.; Powell, D.; Gold, B.T.; Schmitt, F.A. Alzheimer’s Disease in Down Syndrome. Eur. J. Neurodegener. Dis., 2012, 1(3), 353-364.
[PMID: 25285303]

Jiang, Y.; Rigoglioso, A.; Peterhoff, C.M.; Pawlik, M.; Sato, Y.; Bleiwas, C.; Stavrides, P.; Smiley, J.F.; Ginsberg, S.D.; Mathews, P.M.; Levy, E.; Nixon, R.A. Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF. Neurobiol. Aging, 2016, 39, 90-98.
[http://dx.doi.org/10.1016/j.neurobiolaging.2015.11.013] [PMID: 26923405]

Mei, L.; Xiong, W-C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci., 2008, 9(6), 437-452.
[http://dx.doi.org/10.1038/nrn2392] [PMID: 18478032]

Luo, X.; He, W.; Hu, X.; Yan, R. Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in mice. Biol. Psychiatry, 2014, 76(2), 120-127.
[http://dx.doi.org/10.1016/j.biopsych.2013.09.026] [PMID: 24210810]

Seshadri, S.; Kamiya, A.; Yokota, Y.; Prikulis, I.; Kano, S.; Hayashi-Takagi, A.; Stanco, A.; Eom, T.Y.; Rao, S.; Ishizuka, K.; Wong, P.; Korth, C.; Anton, E.S.; Sawa, A. Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc. Natl. Acad. Sci. USA, 2010, 107(12), 5622-5627.
[http://dx.doi.org/10.1073/pnas.0909284107] [PMID: 20212127]

Zhang, Z.; Huang, J.; Shen, Y.; Li, R. BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia. Front. Mol. Neurosci., 2017, 10, 302.
[http://dx.doi.org/10.3389/fnmol.2017.00302] [PMID: 28993723]

Ray, B.; Long, J.M.; Sokol, D.K.; Lahiri, D.K. Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker. PLoS One, 2011, 6(6), e20405.
[http://dx.doi.org/10.1371/journal.pone.0020405] [PMID: 21731612]

Esnafoglu, E. Levels of peripheral Neuregulin 1 are increased in non-medicated autism spectrum disorder patients. J. Clin. Neurosci., 2018, 57, 43-45.
[http://dx.doi.org/10.1016/j.jocn.2018.08.043] [PMID: 30150060]

Ghafouri-Fard, S.; Namvar, A.; Arsang-Jang, S.; Komaki, A.; Taheri, M. Expression analysis of BDNF, BACE1, and their natural occurring antisenses in autistic patients. J. Mol. Neurosci., 2020, 70(2), 194-200.
[http://dx.doi.org/10.1007/s12031-019-01432-7] [PMID: 31760580]

Hu, X.; Hicks, C.W.; He, W.; Wong, P.; Macklin, W.B.; Trapp, B.D.; Yan, R. Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci., 2006, 9(12), 1520-1525.
[http://dx.doi.org/10.1038/nn1797] [PMID: 17099708]

Ou-Yang, M-H.; Kurz, J.E.; Nomura, T.; Popovic, J.; Rajapaksha, T.W.; Dong, H.; Contractor, A.; Chetkovich, D.M.; Tourtellotte, W.G.; Vassar, R. Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice. Sci. Transl. Med., 2018, 10(459), eaao5620.
[http://dx.doi.org/10.1126/scitranslmed.aao5620] [PMID: 30232227]

Vassar, R. Editorial: Implications for BACE1 inhibitor clinical trials: Adult conditional BACE1 knockout mice exhibit axonal organization defects in the hippocampus. J. Prev. Alzheimers Dis., 2019, 6(2), 78-84.
[http://dx.doi.org/10.14283/jpad.2019.3] [PMID: 30756113]

Vassar, R.; Bennett, B.D.; Babu-Khan, S.; Kahn, S.; Mendiaz, E.A.; Denis, P.; Teplow, D.B.; Ross, S.; Amarante, P.; Loeloff, R.; Luo, Y.; Fisher, S.; Fuller, J.; Edenson, S.; Lile, J.; Jarosinski, M.A.; Biere, A.L.; Curran, E.; Burgess, T.; Louis, J.C.; Collins, F.; Treanor, J.; Rogers, G.; Citron, M. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 1999, 286(5440), 735-741.
[http://dx.doi.org/10.1126/science.286.5440.735] [PMID: 10531052]

Voytyuk, I.; Mueller, S.A.; Herber, J.; Snellinx, A.; Moechars, D.; van Loo, G.; Lichtenthaler, S.F.; De Strooper, B. BACE2 distribution in major brain cell types and identification of novel substrates. Life Sci. Alliance, 2018, 1(1), e201800026.
[http://dx.doi.org/10.26508/lsa.201800026] [PMID: 30456346]

Huentelman, M.; De Both, M.; Jepsen, W.; Piras, I.S.; Talboom, J.S.; Willeman, M.; Reiman, E.M.; Hardy, J.; Myers, A.J. Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers. Sci. Rep., 2019, 9(1), 9640.
[http://dx.doi.org/10.1038/s41598-019-45896-4] [PMID: 31270419]

Bennett, B.D.; Babu-Khan, S.; Loeloff, R.; Louis, J.C.; Curran, E.; Citron, M.; Vassar, R. Expression analysis of BACE2 in brain and peripheral tissues. J. Biol. Chem., 2000, 275(27), 20647-20651.
[http://dx.doi.org/10.1074/jbc.M002688200] [PMID: 10749877]

Wilhelm, B.G.; Mandad, S.; Truckenbrodt, S.; Kröhnert, K.; Schäfer, C.; Rammner, B.; Koo, S.J.; Claßen, G.A.; Krauss, M.; Haucke, V.; Urlaub, H.; Rizzoli, S.O. Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science, 2014, 344(6187), 1023-1028.
[http://dx.doi.org/10.1126/science.1252884] [PMID: 24876496]

Seabrook, G.R.; Smith, D.W.; Bowery, B.J.; Easter, A.; Reynolds, T.; Fitzjohn, S.M.; Morton, R.A.; Zheng, H.; Dawson, G.R.; Sirinathsinghji, D.J.; Davies, C.H.; Collingridge, G.L.; Hill, R.G. Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology, 1999, 38(3), 349-359.
[http://dx.doi.org/10.1016/S0028-3908(98)00204-4] [PMID: 10219973]

Rice, H.C.; de Malmazet, D.; Schreurs, A.; Frere, S.; Van Molle, I.; Volkov, A.N.; Creemers, E.; Vertkin, I.; Nys, J.; Ranaivoson, F.M.; Comoletti, D.; Savas, J.N.; Remaut, H.; Balschun, D.; Wierda, K.D.; Slutsky, I.; Farrow, K.; De Strooper, B.; de Wit, J. Secreted amyloid-β precursor protein functions as a GABABR1a ligand to modulate synaptic transmission. Science, 2019, 363(6423), eaao4827.
[http://dx.doi.org/10.1126/science.aao4827] [PMID: 30630900]

Giuffrida, M.L.; Tomasello, M.F.; Pandini, G.; Caraci, F.; Battaglia, G.; Busceti, C.; Di Pietro, P.; Pappalardo, G.; Attanasio, F.; Chiechio, S.; Bagnoli, S.; Nacmias, B.; Sorbi, S.; Vigneri, R.; Rizzarelli, E.; Nicoletti, F.; Copani, A. Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons. Front. Cell. Neurosci., 2015, 9, 297.
[http://dx.doi.org/10.3389/fncel.2015.00297] [PMID: 26300732]

Zimbone, S.; Monaco, I.; Gianì, F.; Pandini, G.; Copani, A.G.; Giuffrida, M.L.; Rizzarelli, E. Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells. Aging Cell, 2018, 17(1), e12684.
[http://dx.doi.org/10.1111/acel.12684] [PMID: 29094448]

Tyan, S-H.; Shih, A.Y-J.; Walsh, J.J.; Maruyama, H.; Sarsoza, F.; Ku, L.; Eggert, S.; Hof, P.R.; Koo, E.H.; Dickstein, D.L. Amyloid precursor protein (APP) regulates synaptic structure and function. Mol. Cell. Neurosci., 2012, 51(1-2), 43-52.
[http://dx.doi.org/10.1016/j.mcn.2012.07.009] [PMID: 22884903]

Abramov, E.; Dolev, I.; Fogel, H.; Ciccotosto, G.D.; Ruff, E.; Slutsky, I. Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat. Neurosci., 2009, 12(12), 1567-1576.
[http://dx.doi.org/10.1038/nn.2433] [PMID: 19935655]

Basi, G.; Frigon, N.; Barbour, R.; Doan, T.; Gordon, G.; McConlogue, L.; Sinha, S.; Zeller, M. Antagonistic effects of beta-site amyloid precursor protein-cleaving enzymes 1 and 2 on beta-amyloid peptide production in cells. J. Biol. Chem., 2003, 278(34), 31512-31520.
[http://dx.doi.org/10.1074/jbc.M300169200] [PMID: 12801932]

Fluhrer, R.; Capell, A.; Westmeyer, G.; Willem, M.; Hartung, B.; Condron, M.M.; Teplow, D.B.; Haass, C.; Walter, J. A non-amyloidogenic function of BACE-2 in the secretory pathway. J. Neurochem., 2002, 81(5), 1011-1020.
[http://dx.doi.org/10.1046/j.1471-4159.2002.00908.x] [PMID: 12065613]

Shi, X-P.; Tugusheva, K.; Bruce, J.E.; Lucka, A.; Wu, G-X.; Chen-Dodson, E.; Price, E.; Li, Y.; Xu, M.; Huang, Q.; Sardana, M.K.; Hazuda, D.J. Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity. J. Biol. Chem., 2003, 278(23), 21286-21294.
[http://dx.doi.org/10.1074/jbc.M209859200] [PMID: 12665519]

Abdul-Hay, S.O.; Sahara, T.; McBride, M.; Kang, D.; Leissring, M.A. Identification of BACE2 as an avid ß-amyloid-degrading protease. Mol. Neurodegener., 2012, 7, 46.
[http://dx.doi.org/10.1186/1750-1326-7-46] [PMID: 22986058]

Dominguez, D.; Tournoy, J.; Hartmann, D.; Huth, T.; Cryns, K.; Deforce, S.; Serneels, L.; Camacho, I.E.; Marjaux, E.; Craessaerts, K.; Roebroek, A.J.; Schwake, M.; D’Hooge, R.; Bach, P.; Kalinke, U.; Moechars, D.; Alzheimer, C.; Reiss, K.; Saftig, P.; De Strooper, B. Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. J. Biol. Chem., 2005, 280(35), 30797-30806.
[http://dx.doi.org/10.1074/jbc.M505249200] [PMID: 15987683]

Yang, J.Z.; Si, T.M.; Ruan, Y.; Ling, Y.S.; Han, Y.H.; Wang, X.L.; Zhou, M.; Zhang, H.Y.; Kong, Q.M.; Liu, C.; Zhang, D.R.; Yu, Y.Q.; Liu, S.Z.; Ju, G.Z.; Shu, L.; Ma, D.L.; Zhang, D. Association study of neuregulin 1 gene with schizophrenia. Mol. Psychiatry, 2003, 8(7), 706-709.
[http://dx.doi.org/10.1038/sj.mp.4001377] [PMID: 12874607]

Yan, R.; Fan, Q.; Zhou, J.; Vassar, R. Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer’s disease. Neurosci. Biobehav. Rev., 2016, 65, 326-340.
[http://dx.doi.org/10.1016/j.neubiorev.2016.03.025] [PMID: 27044452]

Pigoni, M.; Wanngren, J.; Kuhn, P-H.; Munro, K.M.; Gunnersen, J.M.; Takeshima, H.; Feederle, R.; Voytyuk, I.; De Strooper, B.; Levasseur, M.D.; Hrupka, B.J.; Müller, S.A.; Lichtenthaler, S.F. Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons. Mol. Neurodegener., 2016, 11(1), 67.
[http://dx.doi.org/10.1186/s13024-016-0134-z] [PMID: 27716410]

Zhu, K.; Xiang, X.; Filser, S.; Marinković, P.; Dorostkar, M.M.; Crux, S.; Neumann, U.; Shimshek, D.R.; Rammes, G.; Haass, C.; Lichtenthaler, S.F.; Gunnersen, J.M.; Herms, J. Beta-site amyloid precursor protein cleaving enzyme 1 inhibition impairs synaptic plasticity via seizure protein 6. Biol. Psychiatry, 2018, 83(5), 428-437.
[http://dx.doi.org/10.1016/j.biopsych.2016.12.023] [PMID: 28129943]

Barão, S.; Gärtner, A.; Leyva-Díaz, E.; Demyanenko, G.; Munck, S.; Vanhoutvin, T.; Zhou, L.; Schachner, M.; López-Bendito, G.; Maness, P.F.; De Strooper, B. Antagonistic effects of BACE1 and APH1B-γ-secretase control axonal guidance by regulating growth cone collapse. Cell Rep., 2015, 12(9), 1367-1376.
[http://dx.doi.org/10.1016/j.celrep.2015.07.059] [PMID: 26299962]

Hitt, B.; Riordan, S.M.; Kukreja, L.; Eimer, W.A.; Rajapaksha, T.W.; Vassar, R. β-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects. J. Biol. Chem., 2012, 287(46), 38408-38425.
[http://dx.doi.org/10.1074/jbc.M112.415505] [PMID: 22988240]

Wang, Z.; Xu, Q.; Cai, F.; Liu, X.; Wu, Y.; Song, W. BACE2, a conditional β-secretase, contributes to Alzheimer’s disease pathogenesis. JCI Insight, 2019, 4(1), 123431.
[http://dx.doi.org/10.1172/jci.insight.123431] [PMID: 30626751]

Czarnek, M.; Bereta, J. Proteolytic processing of neuregulin 2. Mol. Neurobiol., 2020, 57(4), 1799-1813.
[http://dx.doi.org/10.1007/s12035-019-01846-9] [PMID: 31838721]

Martiskainen, H.; Herukka, S-K.; Stančáková, A.; Paananen, J.; Soininen, H.; Kuusisto, J.; Laakso, M.; Hiltunen, M. Decreased plasma β-amyloid in the Alzheimer’s disease APP A673T variant carriers. Ann. Neurol., 2017, 82(1), 128-132.
[http://dx.doi.org/10.1002/ana.24969] [PMID: 28556232]

Zhou, L.; Brouwers, N.; Benilova, I.; Vandersteen, A.; Mercken, M.; Van Laere, K.; Van Damme, P.; Demedts, D.; Van Leuven, F.; Sleegers, K.; Broersen, K.; Van Broeckhoven, C.; Vandenberghe, R.; De Strooper, B. Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation. EMBO Mol. Med., 2011, 3(5), 291-302.
[http://dx.doi.org/10.1002/emmm.201100138] [PMID: 21500352]

Mullan, M.; Crawford, F.; Axelman, K.; Houlden, H.; Lilius, L.; Winblad, B.; Lannfelt, L. A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet., 1992, 1(5), 345-347.
[http://dx.doi.org/10.1038/ng0892-345] [PMID: 1302033]

Fukumoto, H.; Cheung, B.S.; Hyman, B.T.; Irizarry, M.C. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol., 2002, 59(9), 1381-1389.
[http://dx.doi.org/10.1001/archneur.59.9.1381] [PMID: 12223024]

Zhao, J.; Fu, Y.; Yasvoina, M.; Shao, P.; Hitt, B.; O’Connor, T.; Logan, S.; Maus, E.; Citron, M.; Berry, R.; Binder, L.; Vassar, R. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer’s disease pathogenesis. J. Neurosci., 2007, 27(14), 3639-3649.
[http://dx.doi.org/10.1523/JNEUROSCI.4396-06.2007] [PMID: 17409228]

Sadleir, K.R.; Kandalepas, P.C.; Buggia-Prévot, V.; Nicholson, D.A.; Thinakaran, G.; Vassar, R. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease. Acta Neuropathol., 2016, 132(2), 235-256.
[http://dx.doi.org/10.1007/s00401-016-1558-9] [PMID: 26993139]

Wisniewski, K.E.; Wisniewski, H.M.; Wen, G.Y. Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann. Neurol., 1985, 17(3), 278-282.
[http://dx.doi.org/10.1002/ana.410170310] [PMID: 3158266]

Alić, I.; Goh, P.A.; Murray, A.; Portelius, E.; Gkanatsiou, E.; Gough, G.; Mok, K.Y.; Koschut, D.; Brunmeir, R.; Yeap, Y.J.; O’Brien, N.L.; Groet, J.; Shao, X.; Havlicek, S.; Dunn, N.R.; Kvartsberg, H.; Brinkmalm, G.; Hithersay, R.; Startin, C.; Hamburg, S.; Phillips, M.; Pervushin, K.; Turmaine, M.; Wallon, D.; Rovelet-Lecrux, A.; Soininen, H.; Volpi, E.; Martin, J.E.; Foo, J.N.; Becker, D.L.; Rostagno, A.; Ghiso, J.; Krsnik, Ž.; Šimić, G.; Kostović, I.; Mitrečić, D.; Francis, P.T.; Blennow, K.; Strydom, A.; Hardy, J.; Zetterberg, H.; Nižetić, D. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain. Mol. Psychiatry, 2021, 26(10), 5766-5788.
[http://dx.doi.org/10.1038/s41380-020-0806-5] [PMID: 32647257]

Caraci, F.; Iulita, M.F.; Pentz, R.; Flores Aguilar, L.; Orciani, C.; Barone, C.; Romano, C.; Drago, F.; Cuello, A.C. Searching for new pharmacological targets for the treatment of Alzheimer’s disease in Down syndrome. Eur. J. Pharmacol., 2017, 817, 7-19.
[http://dx.doi.org/10.1016/j.ejphar.2017.10.004] [PMID: 28987272]

Myllykangas, L.; Wavrant-De Vrièze, F.; Polvikoski, T.; Notkola, I-L.; Sulkava, R.; Niinistö, L.; Edland, S.D.; Arepalli, S.; Adighibe, O.; Compton, D.; Hardy, J.; Haltia, M.; Tienari, P.J. Chromosome 21 BACE2 haplotype associates with Alzheimer’s disease: a two-stage study. J. Neurol. Sci., 2005, 236(1-2), 17-24.
[http://dx.doi.org/10.1016/j.jns.2005.04.008] [PMID: 16023140]

Mok, K.Y.; Jones, E.L.; Hanney, M.; Harold, D.; Sims, R.; Williams, J.; Ballard, C.; Hardy, J. Polymorphisms in BACE2 may affect the age of onset Alzheimer’s dementia in Down syndrome. Neurobiol. Aging, 2014, 35(6), 1513.e1-1513.e5.
[http://dx.doi.org/10.1016/j.neurobiolaging.2013.12.022] [PMID: 24462566]

Rovelet-Lecrux, A.; Charbonnier, C.; Wallon, D.; Nicolas, G.; Seaman, M.N.J.; Pottier, C.; Breusegem, S.Y.; Mathur, P.P.; Jenardhanan, P.; Le Guennec, K.; Mukadam, A.S.; Quenez, O.; Coutant, S.; Rousseau, S.; Richard, A.C.; Boland, A.; Deleuze, J.F.; Frebourg, T.; Hannequin, D.; Campion, D. De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease. Mol. Psychiatry, 2015, 20(9), 1046-1056.
[http://dx.doi.org/10.1038/mp.2015.100] [PMID: 26194182]

Holler, C.J.; Webb, R.L.; Laux, A.L.; Beckett, T.L.; Niedowicz, D.M.; Ahmed, R.R.; Liu, Y.; Simmons, C.R.; Dowling, A.L.; Spinelli, A.; Khurgel, M.; Estus, S.; Head, E.; Hersh, L.B.; Murphy, M.P. BACE2 expression increases in human neurodegenerative disease. Am. J. Pathol., 2012, 180(1), 337-350.
[http://dx.doi.org/10.1016/j.ajpath.2011.09.034] [PMID: 22074738]

Qiu, K.; Liang, W.; Wang, S.; Kong, T.; Wang, X.; Li, C.; Wang, Z.; Wu, Y. BACE2 degradation is mediated by both the proteasome and lysosome pathways. BMC Mol. Cell Biol., 2020, 21(1), 13.
[http://dx.doi.org/10.1186/s12860-020-00260-7] [PMID: 32160867]

Thibaudeau, T.A.; Anderson, R.T.; Smith, D.M. A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers. Nat. Commun., 2018, 9(1), 1097.
[http://dx.doi.org/10.1038/s41467-018-03509-0] [PMID: 29545515]

Bettens, K.; Vermeulen, S.; Van Cauwenberghe, C.; Heeman, B.; Asselbergh, B.; Robberecht, C.; Engelborghs, S.; Vandenbulcke, M.; Vandenberghe, R.; De Deyn, P.P.; Cruts, M.; Van Broeckhoven, C.; Sleegers, K. Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations. Mol. Neurodegener., 2015, 10, 30.
[http://dx.doi.org/10.1186/s13024-015-0024-9] [PMID: 26179372]

Ge, S.; Wang, Y.; Song, M.; Li, X.; Yu, X.; Wang, H.; Wang, J.; Zeng, Q.; Wang, W. Type 2 diabetes mellitus: Integrative analysis of multiomics data for biomarker discovery. OMICS, 2018, 22(7), 514-523.
[http://dx.doi.org/10.1089/omi.2018.0053] [PMID: 30004843]

Ghosh, A.K.; Brindisi, M.; Yen, Y-C.; Lendy, E.K.; Kovela, S.; Cárdenas, E.L.; Reddy, B.S.; Rao, K.V.; Downs, D.; Huang, X.; Tang, J.; Mesecar, A.D. Highly selective and potent human β-secretase 2 (BACE2) inhibitors against type 2 diabetes: Design, synthesis, X-ray structure and structure-activity relationship studies. ChemMedChem, 2019, 14(5), 545-560.
[http://dx.doi.org/10.1002/cmdc.201900100] [PMID: 30637955]

Chen, Z.; Zhong, C. Decoding Alzheimer’s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog. Neurobiol., 2013, 108, 21-43.
[http://dx.doi.org/10.1016/j.pneurobio.2013.06.004] [PMID: 23850509]

Biosa, A.; Outeiro, T.F.; Bubacco, L.; Bisaglia, M. Diabetes mellitus as a risk factor for Parkinson’s disease: A molecular point of view. Mol. Neurobiol., 2018, 55(11), 8754-8763.
[http://dx.doi.org/10.1007/s12035-018-1025-9] [PMID: 29594935]

Barbiero, L.; Benussi, L.; Ghidoni, R.; Alberici, A.; Russo, C.; Schettini, G.; Pagano, S.F.; Parati, E.A.; Mazzoli, F.; Nicosia, F.; Signorini, S.; Feudatari, E.; Binetti, G. BACE-2 is overexpressed in Down’s syndrome. Exp. Neurol., 2003, 182(2), 335-345.
[http://dx.doi.org/10.1016/S0014-4886(03)00049-9] [PMID: 12895444]

Sun, X.; He, G.; Song, W. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer’s disease in Down syndrome. FASEB J., 2006, 20(9), 1369-1376.
[http://dx.doi.org/10.1096/fj.05-5632com] [PMID: 16816112]

Kong, D.H.; Kim, Y.K.; Kim, M.R.; Jang, J.H.; Lee, S. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. Int. J. Mol. Sci., 2018, 19(4), E1057.
[http://dx.doi.org/10.3390/ijms19041057] [PMID: 29614819]

Cook-Mills, J.M.; Marchese, M.E.; Abdala-Valencia, H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid. Redox Signal., 2011, 15(6), 1607-1638.
[http://dx.doi.org/10.1089/ars.2010.3522] [PMID: 21050132]

Ballester-López, C.; Conlon, T.M.; Ertüz, Z.; Greiffo, F.R.; Irmler, M.; Verleden, S.E.; Beckers, J.; Fernandez, I.E.; Eickelberg, O.; Yildirim, A.Ö. The Notch ligand DNER regulates macrophage IFNγ release in chronic obstructive pulmonary disease. EBioMedicine, 2019, 43, 562-575.
[http://dx.doi.org/10.1016/j.ebiom.2019.03.054] [PMID: 31060902]

Wang, L.; Wu, Q.; Zhu, S.; Li, Z.; Yuan, J.; Yu, D.; Xu, Z.; Li, J.; Sun, S.; Wang, C. Delta/notch-like epidermal growth factor-related receptor (DNER) orchestrates stemness and cancer progression in prostate cancer. Am. J. Transl. Res., 2017, 9(11), 5031-5039.
[PMID: 29218101]

Sun, P.; Xia, S.; Lal, B.; Eberhart, C.G.; Quinones-Hinojosa, A.; Maciaczyk, J.; Matsui, W.; Dimeco, F.; Piccirillo, S.M.; Vescovi, A.L.; Laterra, J. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells, 2009, 27(7), 1473-1486.
[http://dx.doi.org/10.1002/stem.89] [PMID: 19544453]

Eiraku, M.; Hirata, Y.; Takeshima, H.; Hirano, T.; Kengaku, M. Delta/notch-like epidermal growth factor (EGF)-related receptor, a novel EGF-like repeat-containing protein targeted to dendrites of developing and adult central nervous system neurons. J. Biol. Chem., 2002, 277(28), 25400-25407.
[http://dx.doi.org/10.1074/jbc.M110793200] [PMID: 11950833]

Nanda, A.; Buckhaults, P.; Seaman, S.; Agrawal, N.; Boutin, P.; Shankara, S.; Nacht, M.; Teicher, B.; Stampfl, J.; Singh, S.; Vogelstein, B.; Kinzler, K.W.; St Croix, B. Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R. Cancer Res., 2004, 64(23), 8507-8511.
[http://dx.doi.org/10.1158/0008-5472.CAN-04-2716] [PMID: 15574754]

Miller-Delaney, S.F.C.; Lieberam, I.; Murphy, P.; Mitchell, K.J. Plxdc2 is a mitogen for neural progenitors. PLoS One, 2011, 6(1), e14565.
[http://dx.doi.org/10.1371/journal.pone.0014565] [PMID: 21283688]

Schwarze, S.R.; Fu, V.X.; Desotelle, J.A.; Kenowski, M.L.; Jarrard, D.F. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. Neoplasia, 2005, 7(9), 816-823.
[http://dx.doi.org/10.1593/neo.05250] [PMID: 16229804]

McMurray, H.R.; Sampson, E.R.; Compitello, G.; Kinsey, C.; Newman, L.; Smith, B.; Chen, S.R.; Klebanov, L.; Salzman, P.; Yakovlev, A.; Land, H. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature, 2008, 453(7198), 1112-1116.
[http://dx.doi.org/10.1038/nature06973] [PMID: 18500333]

Hallstrom, T.C.; Mori, S.; Nevins, J.R. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell, 2008, 13(1), 11-22.
[http://dx.doi.org/10.1016/j.ccr.2007.11.031] [PMID: 18167336]

Gaudet, P.; Livstone, M.S.; Lewis, S.E.; Thomas, P.D. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Brief. Bioinform., 2011, 12(5), 449-462.
[http://dx.doi.org/10.1093/bib/bbr042] [PMID: 21873635]

Ornitz, D.M.; Xu, J.; Colvin, J.S.; McEwen, D.G.; MacArthur, C.A.; Coulier, F.; Gao, G.; Goldfarb, M. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem., 1996, 271(25), 15292-15297.
[http://dx.doi.org/10.1074/jbc.271.25.15292] [PMID: 8663044]

Eswarakumar, V.P.; Lax, I.; Schlessinger, J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev., 2005, 16(2), 139-149.
[http://dx.doi.org/10.1016/j.cytogfr.2005.01.001] [PMID: 15863030]

Wang, L.; Song, G.; Tan, W.; Qi, M.; Zhang, L.; Chan, J.; Yu, J.; Han, J.; Han, B. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition. Oncotarget, 2015, 6(34), 35978-35990.
[http://dx.doi.org/10.18632/oncotarget.5427] [PMID: 26451614]

Gunnersen, J.M.; Kim, M.H.; Fuller, S.J.; De Silva, M.; Britto, J.M.; Hammond, V.E.; Davies, P.J.; Petrou, S.; Faber, E.S.; Sah, P.; Tan, S.S. Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons. Neuron, 2007, 56(4), 621-639.
[http://dx.doi.org/10.1016/j.neuron.2007.09.018] [PMID: 18031681]

Håvik, B.; Røkke, H.; Dagyte, G.; Stavrum, A.K.; Bramham, C.R.; Steen, V.M. Synaptic activity-induced global gene expression patterns in the dentate gyrus of adult behaving rats: induction of immunity-linked genes. Neuroscience, 2007, 148(4), 925-936.
[http://dx.doi.org/10.1016/j.neuroscience.2007.07.024] [PMID: 17764852]

Causevic, M.; Dominko, K.; Malnar, M.; Vidatic, L.; Cermak, S.; Pigoni, M.; Kuhn, P.H.; Colombo, A.; Havas, D.; Flunkert, S.; McDonald, J.; Gunnersen, J.M.; Hutter-Paier, B.; Tahirovic, S.; Windisch, M.; Krainc, D.; Lichtenthaler, S.F.; Hecimovic, S. BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains. PLoS One, 2018, 13(7), e0200344.
[http://dx.doi.org/10.1371/journal.pone.0200344] [PMID: 29979789]

Esterházy, D.; Stützer, I.; Wang, H.; Rechsteiner, M.P.; Beauchamp, J.; Döbeli, H.; Hilpert, H.; Matile, H.; Prummer, M.; Schmidt, A.; Lieske, N.; Boehm, B.; Marselli, L.; Bosco, D.; Kerr-Conte, J.; Aebersold, R.; Spinas, G.A.; Moch, H.; Migliorini, C.; Stoffel, M. Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and mass. Cell Metab., 2011, 14(3), 365-377.
[http://dx.doi.org/10.1016/j.cmet.2011.06.018] [PMID: 21907142]

Zhang, H.; Wada, J.; Hida, K.; Tsuchiyama, Y.; Hiragushi, K.; Shikata, K.; Wang, H.; Lin, S.; Kanwar, Y.S.; Makino, H. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J. Biol. Chem., 2001, 276(20), 17132-17139.
[http://dx.doi.org/10.1074/jbc.M006723200] [PMID: 11278314]

Danilczyk, U.; Sarao, R.; Remy, C.; Benabbas, C.; Stange, G.; Richter, A.; Arya, S.; Pospisilik, J.A.; Singer, D.; Camargo, S.M.; Makrides, V.; Ramadan, T.; Verrey, F.; Wagner, C.A.; Penninger, J.M. Essential role for collectrin in renal amino acid transport. Nature, 2006, 444(7122), 1088-1091.
[http://dx.doi.org/10.1038/nature05475] [PMID: 17167413]

Fukui, K.; Yang, Q.; Cao, Y.; Takahashi, N.; Hatakeyama, H.; Wang, H.; Wada, J.; Zhang, Y.; Marselli, L.; Nammo, T.; Yoneda, K.; Onishi, M.; Higashiyama, S.; Matsuzawa, Y.; Gonzalez, F.J.; Weir, G.C.; Kasai, H.; Shimomura, I.; Miyagawa, J.; Wollheim, C.B.; Yamagata, K. The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metab., 2005, 2(6), 373-384.
[http://dx.doi.org/10.1016/j.cmet.2005.11.003] [PMID: 16330323]

Vuille-dit-Bille R.N.; Camargo, S.M.; Emmenegger, L.; Sasse, T.; Kummer, E.; Jando, J.; Hamie, Q.M.; Meier, C.F.; Hunziker, S.; Forras-Kaufmann, Z.; Kuyumcu, S.; Fox, M.; Schwizer, W.; Fried, M.; Lindenmeyer, M.; Götze, O.; Verrey, F. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids, 2015, 47(4), 693-705.
[http://dx.doi.org/10.1007/s00726-014-1889-6] [PMID: 25534429]

Fu, W.; Ruangkittisakul, A.; MacTavish, D.; Shi, J.Y.; Ballanyi, K.; Jhamandas, J.H. Amyloid β (Aβ) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways. J. Biol. Chem., 2012, 287(22), 18820-18830.
[http://dx.doi.org/10.1074/jbc.M111.331181] [PMID: 22500019]

Caruso, G.; Fresta, C.G.; Lazzarino, G.; Distefano, D.A.; Parlascino, P.; Lunte, S.M.; Lazzarino, G.; Caraci, F. Sub-toxic human amylin fragment concentrations promote the survival and proliferation of SH-SY5Y cells via the release of VEGF and HspB5 from endothelial RBE4 cells. Int. J. Mol. Sci., 2018, 19(11), E3659.
[http://dx.doi.org/10.3390/ijms19113659] [PMID: 30463298]

Lorenzo, A.; Razzaboni, B.; Weir, G.C.; Yankner, B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature, 1994, 368(6473), 756-760.
[http://dx.doi.org/10.1038/368756a0] [PMID: 8152488]

Nishi, M.; Sanke, T.; Seino, S.; Eddy, R.L.; Fan, Y.S.; Byers, M.G.; Shows, T.B.; Bell, G.I.; Steiner, D.F. Human islet amyloid polypeptide gene: complete nucleotide sequence, chromosomal localization, and evolutionary history. Mol. Endocrinol., 1989, 3(11), 1775-1781.
[http://dx.doi.org/10.1210/mend-3-11-1775] [PMID: 2608057]

Rulifson, I.C.; Cao, P.; Miao, L.; Kopecky, D.; Huang, L.; White, R.D.; Samayoa, K.; Gardner, J.; Wu, X.; Chen, K.; Tsuruda, T.; Homann, O.; Baribault, H.; Yamane, H.; Carlson, T.; Wiltzius, J.; Li, Y. Identification of Human Islet Amyloid Polypeptide as a BACE2 Substrate. PLoS One, 2016, 11(2), e0147254.
[http://dx.doi.org/10.1371/journal.pone.0147254] [PMID: 26840340]

Hoashi, T.; Watabe, H.; Muller, J.; Yamaguchi, Y.; Vieira, W.D.; Hearing, V.J. MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes. J. Biol. Chem., 2005, 280(14), 14006-14016.
[http://dx.doi.org/10.1074/jbc.M413692200] [PMID: 15695812]

Rochin, L.; Hurbain, I.; Serneels, L.; Fort, C.; Watt, B.; Leblanc, P.; Marks, M.S.; De Strooper, B.; Raposo, G.; van Niel, G. BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells. Proc. Natl. Acad. Sci. USA, 2013, 110(26), 10658-10663.
[http://dx.doi.org/10.1073/pnas.1220748110] [PMID: 23754390]

Mathalon, D.H.; Sullivan, E.V.; Lim, K.O.; Pfefferbaum, A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry, 2001, 58(2), 148-157.
[http://dx.doi.org/10.1001/archpsyc.58.2.148] [PMID: 11177116]

Harrison, P.J.; Law, A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry, 2006, 60(2), 132-140.
[http://dx.doi.org/10.1016/j.biopsych.2005.11.002] [PMID: 16442083]

Pickard, B.S. Schizophrenia biomarkers: translating the descriptive into the diagnostic. J. Psychopharmacol., 2015, 29(2), 138-143.
[http://dx.doi.org/10.1177/0269881114566631] [PMID: 25601396]

Hayashi-Takagi, A.; Vawter, M.P.; Iwamoto, K. Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research. Biol. Psychiatry, 2014, 75(12), 920-928.
[http://dx.doi.org/10.1016/j.biopsych.2013.09.035] [PMID: 24286759]

Stefansson, H.; Sigurdsson, E.; Steinthorsdottir, V.; Bjornsdottir, S.; Sigmundsson, T.; Ghosh, S.; Brynjolfsson, J.; Gunnarsdottir, S.; Ivarsson, O.; Chou, T.T.; Hjaltason, O.; Birgisdottir, B.; Jonsson, H.; Gudnadottir, V.G.; Gudmundsdottir, E.; Bjornsson, A.; Ingvarsson, B.; Ingason, A.; Sigfusson, S.; Hardardottir, H.; Harvey, R.P.; Lai, D.; Zhou, M.; Brunner, D.; Mutel, V.; Gonzalo, A.; Lemke, G.; Sainz, J.; Johannesson, G.; Andresson, T.; Gudbjartsson, D.; Manolescu, A.; Frigge, M.L.; Gurney, M.E.; Kong, A.; Gulcher, J.R.; Petursson, H.; Stefansson, K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet., 2002, 71(4), 877-892.
[http://dx.doi.org/10.1086/342734] [PMID: 12145742]

Walss-Bass, C.; Raventos, H.; Montero, A.P.; Armas, R.; Dassori, A.; Contreras, S.; Liu, W.; Medina, R.; Levinson, D.F.; Pereira, M.; Leach, R.J.; Almasy, L.; Escamilla, M.A. Association analyses of the neuregulin 1 gene with schizophrenia and manic psychosis in a Hispanic population. Acta Psychiatr. Scand., 2006, 113(4), 314-321.
[http://dx.doi.org/10.1111/j.1600-0447.2005.00631.x] [PMID: 16638076]

Fleck, D.; Voss, M.; Brankatschk, B.; Giudici, C.; Hampel, H.; Schwenk, B.; Edbauer, D.; Fukumori, A.; Steiner, H.; Kremmer, E.; Haug-Kröper, M.; Rossner, M.J.; Fluhrer, R.; Willem, M.; Haass, C. Proteolytic Processing of Neuregulin 1 Type III by Three Intramembrane-cleaving Proteases. J. Biol. Chem., 2016, 291(1), 318-333.
[http://dx.doi.org/10.1074/jbc.M115.697995] [PMID: 26574544]

Savonenko, A.V.; Melnikova, T.; Laird, F.M.; Stewart, K-A.; Price, D.L.; Wong, P.C. Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc. Natl. Acad. Sci. USA, 2008, 105(14), 5585-5590.
[http://dx.doi.org/10.1073/pnas.0710373105] [PMID: 18385378]

Buonanno, A. The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits. Brain Res. Bull., 2010, 83(3-4), 122-131.
[http://dx.doi.org/10.1016/j.brainresbull.2010.07.012] [PMID: 20688137]

Mei, L.; Nave, K-A. Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. Neuron, 2014, 83(1), 27-49.
[http://dx.doi.org/10.1016/j.neuron.2014.06.007] [PMID: 24991953]

Wang, H.; Li, R.; Shen, Y. β-Secretase: its biology as a therapeutic target in diseases. Trends Pharmacol. Sci., 2013, 34(4), 215-225.
[http://dx.doi.org/10.1016/j.tips.2013.01.008] [PMID: 23452816]

Allen, N.C.; Bagade, S.; McQueen, M.B.; Ioannidis, J.P.A.; Kavvoura, F.K.; Khoury, M.J.; Tanzi, R.E.; Bertram, L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet., 2008, 40(7), 827-834.
[http://dx.doi.org/10.1038/ng.171] [PMID: 18583979]

Hu, X.; Fan, Q.; Hou, H.; Yan, R. Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling. J. Neurochem., 2016, 136(2), 234-249.
[http://dx.doi.org/10.1111/jnc.13395] [PMID: 26465092]

Hahn, C-G.; Wang, H-Y.; Cho, D-S.; Talbot, K.; Gur, R.E.; Berrettini, W.H.; Bakshi, K.; Kamins, J.; Borgmann-Winter, K.E.; Siegel, S.J.; Gallop, R.J.; Arnold, S.E. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med., 2006, 12(7), 824-828.
[http://dx.doi.org/10.1038/nm1418] [PMID: 16767099]

Krivosheya, D.; Tapia, L.; Levinson, J.N.; Huang, K.; Kang, Y.; Hines, R.; Ting, A.K.; Craig, A.M.; Mei, L.; Bamji, S.X.; El-Husseini, A. ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms. J. Biol. Chem., 2008, 283(47), 32944-32956.
[http://dx.doi.org/10.1074/jbc.M800073200] [PMID: 18819924]

Lang, U.E.; Hellweg, R.; Gallinat, J. Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology, 2005, 30(6), 1148-1153.
[http://dx.doi.org/10.1038/sj.npp.1300666] [PMID: 15668721]

Corfas, G.; Roy, K.; Buxbaum, J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat. Neurosci., 2004, 7(6), 575-580.
[http://dx.doi.org/10.1038/nn1258] [PMID: 15162166]

Barakat, A.; Dean, B.; Scarr, E.; Evin, G. Decreased Neuregulin 1 C-terminal fragment in Brodmann’s area 6 of patients with schizophrenia. Schizophr. Res., 2010, 124(1-3), 200-207.
[http://dx.doi.org/10.1016/j.schres.2010.09.001] [PMID: 20926259]

Dean, B.; Soulby, A.; Evin, G.M.; Scarr, E. Levels of [(3)H]pirenzepine binding in Brodmann’s area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1. Schizophr. Res., 2008, 106(2-3), 229-236.
[http://dx.doi.org/10.1016/j.schres.2008.08.003] [PMID: 18790604]

Marballi, K.; Cruz, D.; Thompson, P.; Walss-Bass, C. Differential neuregulin 1 cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar disorder: preliminary findings. PLoS One, 2012, 7(5), e36431.
[http://dx.doi.org/10.1371/journal.pone.0036431] [PMID: 22590542]

Zhang, Z.; Cui, J.; Gao, F.; Li, Y.; Zhang, G.; Liu, M.; Yan, R.; Shen, Y.; Li, R. Elevated cleavage of neuregulin-1 by beta-secretase 1 in plasma of schizophrenia patients. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2019, 90, 161-168.
[http://dx.doi.org/10.1016/j.pnpbp.2018.11.018] [PMID: 30500411]

Zhang, Z.; Li, Y.; He, F.; Cui, Y.; Zheng, Y.; Li, R. Sex differences in circulating neuregulin1-β1 and β-secretase 1 expression in childhood-onset schizophrenia. Compr. Psychiatry, 2020, 100, 152176.
[http://dx.doi.org/10.1016/j.comppsych.2020.152176] [PMID: 32430144]

Shibuya, M.; Komi, E.; Wang, R.; Kato, T.; Watanabe, Y.; Sakai, M.; Ozaki, M.; Someya, T.; Nawa, H. Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism. J. Neural Transm. (Vienna), 2010, 117(7), 887-895.
[http://dx.doi.org/10.1007/s00702-010-0418-3] [PMID: 20526724]

Muthusamy, N.; Faundez, V.; Bergson, C. Calcyon, a mammalian specific NEEP21 family member, interacts with adaptor protein complex 3 (AP-3) and regulates targeting of AP-3 cargoes. J. Neurochem., 2012, 123(1), 60-72.
[http://dx.doi.org/10.1111/j.1471-4159.2012.07814.x] [PMID: 22650988]

Alberi, S.; Boda, B.; Steiner, P.; Nikonenko, I.; Hirling, H.; Muller, D. The endosomal protein NEEP21 regulates AMPA receptor-mediated synaptic transmission and plasticity in the hippocampus. Mol. Cell. Neurosci., 2005, 29(2), 313-319.
[http://dx.doi.org/10.1016/j.mcn.2005.03.011] [PMID: 15911354]

Norstrom, E.M.; Zhang, C.; Tanzi, R.; Sisodia, S.S. Identification of NEEP21 as a ß-amyloid precursor protein-interacting protein in vivo that modulates amyloidogenic processing in vitro. J. Neurosci., 2010, 30(46), 15677-15685.
[http://dx.doi.org/10.1523/JNEUROSCI.4464-10.2010] [PMID: 21084623]

Trantham-Davidson, H.; Vazdarjanova, A.; Dai, R.; Terry, A.; Bergson, C. Up-regulation of calcyon results in locomotor hyperactivity and reduced anxiety in mice. Behav. Brain Res., 2008, 189(2), 244-249.
[http://dx.doi.org/10.1016/j.bbr.2007.12.031] [PMID: 18295356]

Vazdarjanova, A.; Bunting, K.; Muthusamy, N.; Bergson, C. Calcyon upregulation in adolescence impairs response inhibition and working memory in adulthood. Mol. Psychiatry, 2011, 16(6), 672-684.
[http://dx.doi.org/10.1038/mp.2011.14] [PMID: 21403673]

Kato, T.; Kasai, A.; Mizuno, M.; Fengyi, L.; Shintani, N.; Maeda, S.; Yokoyama, M.; Ozaki, M.; Nawa, H. Phenotypic characterization of transgenic mice overexpressing neuregulin-1. PLoS One, 2010, 5(12), e14185.
[http://dx.doi.org/10.1371/journal.pone.0014185] [PMID: 21151609]

Yin, D-M.; Chen, Y-J.; Liu, S.; Jiao, H.; Shen, C.; Sathyamurthy, A.; Lin, T.W.; Xiong, W.C.; Li, B.M.; Mei, L.; Bergson, C. Calcyon stimulates neuregulin 1 maturation and signaling. Mol. Psychiatry, 2015, 20(10), 1251-1260.
[http://dx.doi.org/10.1038/mp.2014.131] [PMID: 25349163]

Kumari, V.; Das, M.; Zachariah, E.; Ettinger, U.; Sharma, T. Reduced prepulse inhibition in unaffected siblings of schizophrenia patients. Psychophysiology, 2005, 42(5), 588-594.
[http://dx.doi.org/10.1111/j.1469-8986.2005.00346.x] [PMID: 16176381]

Cadenhead, K.S.; Swerdlow, N.R.; Shafer, K.M.; Diaz, M.; Braff, D.L. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am. J. Psychiatry, 2000, 157(10), 1660-1668.
[http://dx.doi.org/10.1176/appi.ajp.157.10.1660] [PMID: 11007721]

Hennah, W.; Thomson, P.; Peltonen, L.; Porteous, D. Genes and schizophrenia: beyond schizophrenia: the role of DISC1 in major mental illness. Schizophr. Bull., 2006, 32(3), 409-416.
[http://dx.doi.org/10.1093/schbul/sbj079] [PMID: 16699061]

Deng, Q-S.; Dong, X-Y.; Wu, H.; Wang, W.; Wang, Z-T.; Zhu, J-W.; Liu, C.F.; Jia, W.Q.; Zhang, Y.; Schachner, M.; Ma, Q.H.; Xu, R.X. Disrupted-in-schizophrenia-1 attenuates amyloid-β generation and cognitive deficits in APP/PS1 transgenic mice by reduction of β-Site APP-cleaving enzyme 1 levels. Neuropsychopharmacology, 2016, 41(2), 440-453.
[http://dx.doi.org/10.1038/npp.2015.164] [PMID: 26062786]

Wang, Z-T.; Lu, M-H.; Zhang, Y.; Ji, W-L.; Lei, L.; Wang, W.; Fang, L.P.; Wang, L.W.; Yu, F.; Wang, J.; Li, Z.Y.; Wang, J.R.; Wang, T.H.; Dou, F.; Wang, Q.W.; Wang, X.L.; Li, S.; Ma, Q.H.; Xu, R.X. Disrupted-in-schizophrenia-1 protects synaptic plasticity in a transgenic mouse model of Alzheimer’s disease as a mitophagy receptor. Aging Cell, 2019, 18(1), e12860.
[http://dx.doi.org/10.1111/acel.12860] [PMID: 30488644]

Paredes, R.M.; Piccart, E.; Navaira, E.; Cruz, D.; Javors, M.A.; Koek, W.; Beckstead, M.J.; Walss-Bass, C. Physiological and behavioral effects of amphetamine in BACE1(-/-) mice. Genes Brain Behav., 2015, 14(5), 411-418.
[http://dx.doi.org/10.1111/gbb.12222] [PMID: 25912880]

Ledonne, A.; Mercuri, N.B. mGluR1-dependent long term depression in rodent midbrain dopamine neurons is regulated by neuregulin 1/ErbB signaling. Front. Mol. Neurosci., 2018, 11, 346.
[http://dx.doi.org/10.3389/fnmol.2018.00346] [PMID: 30327588]

Ledonne, A.; Nobili, A.; Latagliata, E.C.; Cavallucci, V.; Guatteo, E.; Puglisi-Allegra, S.; D’Amelio, M.; Mercuri, N.B. Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons. Mol. Psychiatry, 2015, 20(8), 959-973.
[http://dx.doi.org/10.1038/mp.2014.109] [PMID: 25266126]

Stertz, L.; Contreras-Shannon, V.; Monroy-Jaramillo, N.; Sun, J.; Walss-Bass, C. BACE1-deficient mice exhibit alterations in immune system pathways. Mol. Neurobiol., 2018, 55(1), 709-717.
[http://dx.doi.org/10.1007/s12035-016-0341-1] [PMID: 28004339]

Xu, J.; Sun, J.; Chen, J.; Wang, L.; Li, A.; Helm, M.; Dubovsky, S.L.; Bacanu, S.A.; Zhao, Z.; Chen, X. RNA-Seq analysis implicates dysregulation of the immune system in schizophrenia. BMC Genomics, 2012, 13(Suppl. 8), S2.
[http://dx.doi.org/10.1186/1471-2164-13-S8-S2] [PMID: 23282246]

Dimitrov, D.H.; Lee, S.; Yantis, J.; Valdez, C.; Paredes, R.M.; Braida, N.; Velligan, D.; Walss-Bass, C. Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway. Schizophr. Res., 2013, 151(1-3), 29-35.
[http://dx.doi.org/10.1016/j.schres.2013.10.019] [PMID: 24210870]

Gandal, M.J.; Haney, J.R.; Parikshak, N.N.; Leppa, V.; Ramaswami, G.; Hartl, C.; Schork, A.J.; Appadurai, V.; Buil, A.; Werge, T.M.; Liu, C.; White, K.P.; Horvath, S.; Geschwind, D.H. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science, 2018, 359(6376), 693-697.
[http://dx.doi.org/10.1126/science.aad6469] [PMID: 29439242]

Cheung, C.; Yu, K.; Fung, G.; Leung, M.; Wong, C.; Li, Q.; Sham, P.; Chua, S.; McAlonan, G. Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. PLoS One, 2010, 5(8), e12233.
[http://dx.doi.org/10.1371/journal.pone.0012233] [PMID: 20805880]

Yoo, H.J.; Woo, R-S.; Cho, S-C.; Kim, B-N.; Kim, J-W.; Shin, M-S.; Park, T.W.; Son, J.W.; Chung, U.S.; Park, S.; Park, M.; Kim, S.A. Genetic association analyses of neuregulin 1 gene polymorphism with endopheontype for sociality of Korean autism spectrum disorders family. Psychiatry Res., 2015, 227(2-3), 366-368.
[http://dx.doi.org/10.1016/j.psychres.2015.03.015] [PMID: 25858800]

Sokol, D.K.; Chen, D.; Farlow, M.R.; Dunn, D.W.; Maloney, B.; Zimmer, J.A.; Lahiri, D.K. High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J. Child Neurol., 2006, 21(6), 444-449.
[http://dx.doi.org/10.1177/08830738060210062201] [PMID: 16948926]

Lahiri, D.K.; Sokol, D.K.; Erickson, C.; Ray, B.; Ho, C.Y.; Maloney, B. Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathway. Front. Cell. Neurosci., 2013, 7, 94.
[http://dx.doi.org/10.3389/fncel.2013.00094] [PMID: 23801940]

Wang, Y-Y.; Zhao, B.; Wu, M-M.; Zheng, X-L.; Lin, L.; Yin, D-M. Overexpression of neuregulin 1 in GABAergic interneurons results in reversible cortical disinhibition. Nat. Commun., 2021, 12(1), 278.
[http://dx.doi.org/10.1038/s41467-020-20552-y] [PMID: 33436636]

Feng, T.; Tammineni, P.; Agrawal, C.; Jeong, Y.Y.; Cai, Q. Autophagy-mediated Regulation of BACE1 Protein Trafficking and Degradation. J. Biol. Chem., 2017, 292(5), 1679-1690.
[http://dx.doi.org/10.1074/jbc.M116.766584] [PMID: 28028177]

Do Carmo, S.; Hanzel, C.E.; Jacobs, M.L.; Machnes, Z.; Iulita, M.F.; Yang, J.; Yu, L.; Ducatenzeiler, A.; Danik, M.; Breuillaud, L.S.; Bennett, D.A.; Szyf, M.; Cuello, A.C. Rescue of early bace-1 and global DNA demethylation by S-adenosylmethionine reduces amyloid pathology and improves cognition in an Alzheimer’s model. Sci. Rep., 2016, 6, 34051.
[http://dx.doi.org/10.1038/srep34051] [PMID: 27681803]

Tan, G-H.; Liu, Y-Y.; Hu, X-L.; Yin, D-M.; Mei, L.; Xiong, Z-Q. Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons. Nat. Neurosci., 2011, 15(2), 258-266.
[http://dx.doi.org/10.1038/nn.3005] [PMID: 22158510]

Li, K-X.; Lu, Y-M.; Xu, Z-H.; Zhang, J.; Zhu, J-M.; Zhang, J-M.; Cao, S.X.; Chen, X.J.; Chen, Z.; Luo, J.H.; Duan, S.; Li, X.M. Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat. Neurosci., 2011, 15(2), 267-273.
[http://dx.doi.org/10.1038/nn.3006] [PMID: 22158511]

Gabrielsen, T.P.; Anderson, J.S.; Stephenson, K.G.; Beck, J.; King, J.B.; Kellems, R.; Top, D.N., Jr; Russell, N.C.C.; Anderberg, E.; Lundwall, R.A.; Hansen, B.; South, M. Functional MRI connectivity of children with autism and low verbal and cognitive performance. Mol. Autism, 2018, 9, 67.
[http://dx.doi.org/10.1186/s13229-018-0248-y] [PMID: 30603063]

Penault-Llorca, F.; Rudzinski, E.R.; Sepulveda, A.R. Testing algorithm for identification of patients with TRK fusion cancer. J. Clin. Pathol., 2019, 72(7), 460-467.
[http://dx.doi.org/10.1136/jclinpath-2018-205679] [PMID: 31072837]

Le, D.T.; Durham, J.N.; Smith, K.N.; Wang, H.; Bartlett, B.R.; Aulakh, L.K.; Lu, S.; Kemberling, H.; Wilt, C.; Luber, B.S.; Wong, F.; Azad, N.S.; Rucki, A.A.; Laheru, D.; Donehower, R.; Zaheer, A.; Fisher, G.A.; Crocenzi, T.S.; Lee, J.J.; Greten, T.F.; Duffy, A.G.; Ciombor, K.K.; Eyring, A.D.; Lam, B.H.; Joe, A.; Kang, S.P.; Holdhoff, M.; Danilova, L.; Cope, L.; Meyer, C.; Zhou, S.; Goldberg, R.M.; Armstrong, D.K.; Bever, K.M.; Fader, A.N.; Taube, J.; Housseau, F.; Spetzler, D.; Xiao, N.; Pardoll, D.M.; Papadopoulos, N.; Kinzler, K.W.; Eshleman, J.R.; Vogelstein, B.; Anders, R.A.; Diaz, L.A. Jr Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science, 2017, 357(6349), 409-413.
[http://dx.doi.org/10.1126/science.aan6733] [PMID: 28596308]

Drilon, A.; Laetsch, T.W.; Kummar, S.; DuBois, S.G.; Lassen, U.N.; Demetri, G.D.; Nathenson, M.; Doebele, R.C.; Farago, A.F.; Pappo, A.S.; Turpin, B.; Dowlati, A.; Brose, M.S.; Mascarenhas, L.; Federman, N.; Berlin, J.; El-Deiry, W.S.; Baik, C.; Deeken, J.; Boni, V.; Nagasubramanian, R.; Taylor, M.; Rudzinski, E.R.; Meric-Bernstam, F.; Sohal, D.P.S.; Ma, P.C.; Raez, L.E.; Hechtman, J.F.; Benayed, R.; Ladanyi, M.; Tuch, B.B.; Ebata, K.; Cruickshank, S.; Ku, N.C.; Cox, M.C.; Hawkins, D.S.; Hong, D.S.; Hyman, D.M. Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N. Engl. J. Med., 2018, 378(8), 731-739.
[http://dx.doi.org/10.1056/NEJMoa1714448] [PMID: 29466156]

Drost, J.; Clevers, H. Organoids in cancer research. Nat. Rev. Cancer, 2018, 18(7), 407-418.
[http://dx.doi.org/10.1038/s41568-018-0007-6] [PMID: 29692415]

Ballard, D.H.; Boyer, C.J.; Alexander, J.S. Organoids - preclinical models of human disease. N. Engl. J. Med., 2019, 380(20), 1981-1982.
[http://dx.doi.org/10.1056/NEJMc1903253] [PMID: 31091396]

Siravegna, G.; Marsoni, S.; Siena, S.; Bardelli, A. Integrating liquid biopsies into the management of cancer. Nat. Rev. Clin. Oncol., 2017, 14(9), 531-548.
[http://dx.doi.org/10.1038/nrclinonc.2017.14] [PMID: 28252003]

Parikh, A.R.; Leshchiner, I.; Elagina, L.; Goyal, L.; Levovitz, C.; Siravegna, G.; Livitz, D.; Rhrissorrakrai, K.; Martin, E.E.; Van Seventer, E.E.; Hanna, M.; Slowik, K.; Utro, F.; Pinto, C.J.; Wong, A.; Danysh, B.P.; de la Cruz, F.F.; Fetter, I.J.; Nadres, B.; Shahzade, H.A.; Allen, J.N.; Blaszkowsky, L.S.; Clark, J.W.; Giantonio, B.; Murphy, J.E.; Nipp, R.D.; Roeland, E.; Ryan, D.P.; Weekes, C.D.; Kwak, E.L.; Faris, J.E.; Wo, J.Y.; Aguet, F.; Dey-Guha, I.; Hazar-Rethinam, M.; Dias-Santagata, D.; Ting, D.T.; Zhu, A.X.; Hong, T.S.; Golub, T.R.; Iafrate, A.J.; Adalsteinsson, V.A.; Bardelli, A.; Parida, L.; Juric, D.; Getz, G.; Corcoran, R.B. Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. Nat. Med., 2019, 25(9), 1415-1421.
[http://dx.doi.org/10.1038/s41591-019-0561-9] [PMID: 31501609]

Marchiò, C.; Scaltriti, M.; Ladanyi, M.; Iafrate, A.J.; Bibeau, F.; Dietel, M.; Hechtman, J.F.; Troiani, T.; López-Rios, F.; Douillard, J.Y.; Andrè, F.; Reis-Filho, J.S. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research. Ann. Oncol., 2019, 30(9), 1417-1427.
[http://dx.doi.org/10.1093/annonc/mdz204] [PMID: 31268127]

Shah, P.; Kendall, F.; Khozin, S.; Goosen, R.; Hu, J.; Laramie, J.; Ringel, M.; Schork, N. Artificial intelligence and machine learning in clinical development: a translational perspective. NPJ Digit. Med., 2019, 2, 69.
[http://dx.doi.org/10.1038/s41746-019-0148-3] [PMID: 31372505]

Hong, D.S.; DuBois, S.G.; Kummar, S.; Farago, A.F.; Albert, C.M.; Rohrberg, K.S.; van Tilburg, C.M.; Nagasubramanian, R.; Berlin, J.D.; Federman, N.; Mascarenhas, L.; Geoerger, B.; Dowlati, A.; Pappo, A.S.; Bielack, S.; Doz, F.; McDermott, R.; Patel, J.D.; Schilder, R.J.; Tahara, M.; Pfister, S.M.; Witt, O.; Ladanyi, M.; Rudzinski, E.R.; Nanda, S.; Childs, B.H.; Laetsch, T.W.; Hyman, D.M.; Drilon, A. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. Lancet Oncol., 2020, 21(4), 531-540.
[http://dx.doi.org/10.1016/S1470-2045(19)30856-3] [PMID: 32105622]

Bassett, D.S.; Sporns, O. Network neuroscience. Nat. Neurosci., 2017, 20(3), 353-364.
[http://dx.doi.org/10.1038/nn.4502] [PMID: 28230844]

Shine, J.M.; Breakspear, M.; Bell, P.T.; Ehgoetz Martens, K.A.; Shine, R.; Koyejo, O.; Sporns, O.; Poldrack, R.A. Human cognition involves the dynamic integration of neural activity and neuromodulatory systems. Nat. Neurosci., 2019, 22(2), 289-296.
[http://dx.doi.org/10.1038/s41593-018-0312-0] [PMID: 30664771]

Chiesa, P.A.; Houot, M.; Vergallo, A.; Cavedo, E.; Lista, S.; Potier, M.C.; Zetterberg, H.; Blennow, K.; Vanmechelen, E.; De Vos, A.; Dubois, B.; Hampel, H. Association of brain network dynamics with plasma biomarkers in subjective memory complainers. Neurobiol. Aging, 2020, 88, 83-90.
[http://dx.doi.org/10.1016/j.neurobiolaging.2019.12.017] [PMID: 32087948]

Shen, Y.; Wang, H.; Sun, Q.; Yao, H.; Keegan, A.P.; Mullan, M.; Wilson, J.; Lista, S.; Leyhe, T.; Laske, C.; Rujescu, D.; Levey, A.; Wallin, A.; Blennow, K.; Li, R.; Hampel, H. Increased plasma beta-secretase 1 may predict conversion to Alzheimer’s disease dementia in individuals with mild cognitive impairment. Biol. Psychiatry, 2018, 83(5), 447-455.
[http://dx.doi.org/10.1016/j.biopsych.2017.02.007] [PMID: 28359566]

Vergallo, A.; Lemercier, P.; Cavedo, E.; Lista, S.; Vanmechelen, E.; De Vos, A.; Zetterberg, H.; Blennow, K.; Habert, M.O.; Potier, M.C.; Dubois, B.; Teipel, S.; Hampel, H. Plasma β-secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD. Alzheimers Dement., 2021, 17(4), 629-640.
[http://dx.doi.org/10.1002/alz.12228] [PMID: 33527718]

Vergallo, A.; Houot, M.; Cavedo, E.; Lemercier, P.; Vanmechelen, E.; De Vos, A.; Habert, M.O.; Potier, M.C.; Dubois, B.; Lista, S.; Hampel, H. Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD. Alzheimers Dement., 2019, 15(10), 1274-1285.
[http://dx.doi.org/10.1016/j.jalz.2019.07.001] [PMID: 31627825]

Schipke, C.G.; De Vos, A.; Fuentes, M.; Jacobs, D.; Vanmechelen, E.; Peters, O. Neurogranin and BACE1 in CSF as potential biomarkers differentiating depression with cognitive deficits from early Alzheimer’s disease: A pilot study. Dement. Geriatr. Cogn. Disord. Extra, 2018, 8(2), 277-289.
[http://dx.doi.org/10.1159/000489847] [PMID: 30186306]

Zetterberg, H.; Andreasson, U.; Hansson, O.; Wu, G.; Sankaranarayanan, S.; Andersson, M.E.; Buchhave, P.; Londos, E.; Umek, R.M.; Minthon, L.; Simon, A.J.; Blennow, K. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch. Neurol., 2008, 65(8), 1102-1107.
[http://dx.doi.org/10.1001/archneur.65.8.1102] [PMID: 18695061]

Ewers, M.; Cheng, X.; Zhong, Z.; Nural, H.F.; Walsh, C.; Meindl, T.; Teipel, S.J.; Buerger, K.; He, P.; Shen, Y.; Hampel, H. Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer’s disease. J. Alzheimers Dis., 2011, 25(2), 373-381.
[http://dx.doi.org/10.3233/JAD-2011-091153] [PMID: 21460439]

Vergallo, A.; Lista, S.; Zhao, Y.; Lemercier, P.; Teipel, S.J.; Potier, M-C.; Habert, M.O.; Dubois, B.; Lukiw, W.J.; Hampel, H. MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints. Transl. Psychiatry, 2021, 11(1), 78.
[http://dx.doi.org/10.1038/s41398-020-01184-8] [PMID: 33504764]

Williamson, P.C.; Allman, J.M. A framework for interpreting functional networks in schizophrenia. Front. Hum. Neurosci., 2012, 6, 184.
[http://dx.doi.org/10.3389/fnhum.2012.00184] [PMID: 22737116]

Vercammen, A.; Knegtering, H.; den Boer, J.A.; Liemburg, E.J.; Aleman, A. Auditory hallucinations in schizophrenia are associated with reduced functional connectivity of the temporo-parietal area. Biol. Psychiatry, 2010, 67(10), 912-918.
[http://dx.doi.org/10.1016/j.biopsych.2009.11.017] [PMID: 20060103]

Dekhil, O.; Hajjdiab, H.; Shalaby, A.; Ali, M.T.; Ayinde, B.; Switala, A.; Elshamekh, A.; Ghazal, M.; Keynton, R.; Barnes, G.; El-Baz, A. Using resting state functional MRI to build a personalized autism diagnosis system. PLoS One, 2018, 13(10), e0206351.
[http://dx.doi.org/10.1371/journal.pone.0206351] [PMID: 30379950]

Reininghaus, U.; Böhnke, J.R.; Chavez-Baldini, U.; Gibbons, R.; Ivleva, E.; Clementz, B.A.; Pearlson, G.D.; Keshavan, M.S.; Sweeney, J.A.; Tamminga, C.A. Transdiagnostic dimensions of psychosis in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP). World Psychiatry, 2019, 18(1), 67-76.
[http://dx.doi.org/10.1002/wps.20607] [PMID: 30600629]

Hampel, H.; Lista, S.; Vergallo, A. Commentary: Development of the blood-based Alzheimer’s disease liquid biopsy. J. Prev. Alzheimers Dis., 2019, 6(3), 182-184.
[http://dx.doi.org/10.14283/jpad.2019.22] [PMID: 31062832]

Hampel, H.; Lista, S.; Vanmechelen, E.; Zetterberg, H.; Giorgi, F.S.; Galgani, A.; Blennow, K.; Caraci, F.; Das, B.; Yan, R.; Vergallo, A. β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification. Alzheimers Res. Ther., 2020, 12(1), 130.
[http://dx.doi.org/10.1186/s13195-020-00686-3] [PMID: 33066807]

Musante, C.J.; Ramanujan, S.; Schmidt, B.J.; Ghobrial, O.G.; Lu, J.; Heatherington, A.C. Quantitative systems pharmacology: A case for disease models. Clin. Pharmacol. Ther., 2017, 101(1), 24-27.
[http://dx.doi.org/10.1002/cpt.528] [PMID: 27709613]

Geerts, H.; Hofmann-Apitius, M.; Anastasio, T.J. Knowledgedriven computational modeling in Alzheimer’s disease research: Current state and future trends. Alzheimers Dement, 2017, 13(11), 1292-1302.
[http://dx.doi.org/10.1016/j.jalz.2017.08.011] [PMID: 28917669]

Lyu, J.; Wang, S.; Balius, T.E.; Singh, I.; Levit, A.; Moroz, Y.S.; O’Meara, M.J.; Che, T.; Algaa, E.; Tolmachova, K.; Tolmachev, A.A.; Shoichet, B.K.; Roth, B.L.; Irwin, J.J. Ultra-large library docking for discovering new chemotypes. Nature, 2019, 566(7743), 224-229.
[http://dx.doi.org/10.1038/s41586-019-0917-9] [PMID: 30728502]

Harrold, J.M.; Ramanathan, M.; Mager, D.E. Network-based approaches in drug discovery and early development. Clin. Pharmacol. Ther., 2013, 94(6), 651-658.
[http://dx.doi.org/10.1038/clpt.2013.176] [PMID: 24025802]

Geerts, H.; Spiros, A.; Roberts, P.; Carr, R. Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer’s disease. Eur. J. Pharmacol., 2017, 817, 38-45.
[http://dx.doi.org/10.1016/j.ejphar.2017.05.062] [PMID: 28583429]

Leil, T.A.; Bertz, R. Quantitative Systems Pharmacology can reduce attrition and improve productivity in pharmaceutical research and development. Front. Pharmacol., 2014, 5, 247.
[http://dx.doi.org/10.3389/fphar.2014.00247] [PMID: 25426074]

Diaz, K.; Lancashire, L.; Jeromin, A.; Haas, M.; Spiros, A.; Geerts, H. P2-102: MAPTA: Modeling alliance of systems pharmacology in tauopathies. Alzheimers Dement., 2018, 14(75), 707.
[http://dx.doi.org/10.1016/j.jalz.2018.06.788]

Ly, P.T.; Wu, Y.; Zou, H.; Wang, R.; Zhou, W.; Kinoshita, A.; Zhang, M.; Yang, Y.; Cai, F.; Woodgett, J.; Song, W. Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J. Clin. Invest., 2013, 123(1), 224-235.
[http://dx.doi.org/10.1172/JCI64516] [PMID: 23202730]

Calabrese, V.; Cornelius, C.; Dinkova-Kostova, A.T.; Calabrese, E.J.; Mattson, M.P. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid. Redox Signal., 2010, 13(11), 1763-1811.
[http://dx.doi.org/10.1089/ars.2009.3074] [PMID: 20446769]

Calabrese, V.; Copani, A.; Testa, D.; Ravagna, A.; Spadaro, F.; Tendi, E.; Nicoletti, V.G.; Giuffrida Stella, A.M. Nitric oxide synthase induction in astroglial cell cultures: effect on heat shock protein 70 synthesis and oxidant/antioxidant balance. J. Neurosci. Res., 2000, 60(5), 613-622.
[http://dx.doi.org/10.1002/(SICI)1097-4547(20000601)60:5<613:AID-JNR6>3.0.CO;2-8] [PMID: 10820432]

Dattilo, S.; Mancuso, C.; Koverech, G.; Di Mauro, P.; Ontario, M.L.; Petralia, C.C.; Petralia, A.; Maiolino, L.; Serra, A.; Calabrese, E.J.; Calabrese, V. Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases. Immun. Ageing, 2015, 12, 20.
[http://dx.doi.org/10.1186/s12979-015-0046-8] [PMID: 26543490]

Richards, B.A.; Lillicrap, T.P.; Beaudoin, P.; Bengio, Y.; Bogacz, R.; Christensen, A.; Clopath, C.; Costa, R.P.; de Berker, A.; Ganguli, S.; Gillon, C.J.; Hafner, D.; Kepecs, A.; Kriegeskorte, N.; Latham, P.; Lindsay, G.W.; Miller, K.D.; Naud, R.; Pack, C.C.; Poirazi, P.; Roelfsema, P.; Sacramento, J.; Saxe, A.; Scellier, B.; Schapiro, A.C.; Senn, W.; Wayne, G.; Yamins, D.; Zenke, F.; Zylberberg, J.; Therien, D.; Kording, K.P. A deep learning framework for neuroscience. Nat. Neurosci., 2019, 22(11), 1761-1770.
[http://dx.doi.org/10.1038/s41593-019-0520-2] [PMID: 31659335]

Aggarwal, C.C.; Hinneburg, A.; Keim, D.A. On the Surprising Behavior of Distance Metrics in High Dimensional Space. In: International Conference on Database Theory. Database Theory — ICDT 2001. Lecture Notes in Computer Science book series (LNCS); Van den Bussche, J; Vianu , V Springer: Berlin, Heidelberg, 2001; 1973, pp. 420-434.
[http://dx.doi.org/10.1007/3-540-44503-X_27]

Lydon-Staley, D.M.; Cornblath, E.J.; Blevins, A.S.; Bassett, D.S. Modeling brain, symptom, and behavior in the winds of change. Neuropsychopharmacology, 2021, 46(1), 20-32.
[http://dx.doi.org/10.1038/s41386-020-00805-6] [PMID: 32859996]

Saxe, A.; Nelli, S.; Summerfield, C. If deep learning is the answer, what is the question? Nat. Rev. Neurosci., 2021, 22(1), 55-67.
[http://dx.doi.org/10.1038/s41583-020-00395-8] [PMID: 33199854]

Molnar, C. Interpretable machine learning. A Guide for Making Black Box Models Explainable 2019. Available from: https://christophm.github.io/interpretable-ml-book/ (Accessed November 17, 2021).

Kundu, S. AI in medicine must be explainable. Nat. Med., 2021, 27(8), 1328.
[http://dx.doi.org/10.1038/s41591-021-01461-z] [PMID: 34326551]